Global Regulatory Affairs Outsourcing Market to Reach US$ 11.7 Billion by 2028, Propelled by the Exponential Growth in the Biotechnological and Pharmaceutical Industries

October 12, 2022 | Healthcare

The latest report by IMARC, titled “Regulatory Affairs Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, finds that the global regulatory affairs market size reached US$ 7.1 Billion in 2022. Regulatory affairs outsourcing refers to the hiring process of third-party services by private organizations and government bodies in order to ensure public health and safety. These services include managing regulatory requirements for innovator drugs, generic drugs, biosimilars, biologics, and others. Outsourcing organizations ensure the safety and efficacy of the products while ensuring they are safe for consumption. These services are used for regulatory writing and publishing, clinical trial and patent application, legal representation, and product registration. In recent years, regulatory affairs outsourcing has gained momentum due to its adoption in pharmaceutical companies for achieving speedy government approvals.

Global Regulatory Affairs Outsourcing Market Trends:

One of the primary factors driving the market is the exponential growth in the biotechnological and pharmaceutical industries. Additionally, the increasing focus of pharmaceutical industries on expanding their supplies and operations in developing economies is creating a positive market outlook. Other than this, regulatory affairs outsourcing services are employed to produce orphan, biosimilar, and generic drugs. Besides this, these services reduce the costs of managing in-house resources, including training, facilities, technology, specialized knowledge, and geographic regulations. This, along with the increasing number of trials, is boosting the demand for regulatory affairs outsourcing. Furthermore, extensive research and development (R&D) activities, improvements in the healthcare industry, and a rise in the number of FDA-approved manufacturing plants are catalyzing the market growth. Looking forward, IMARC Group expects the market size to reach US$ 11.7 Billion by 2028, expanding at a CAGR of 8.6% during the forecast period (2023-2028).

Market Summary:

Based on the services, the market has been divided into regulatory consulting, legal representation, regulatory writing and publishing, product registration and clinical trial applications, and others.
On the basis of the company size, the market has been segmented into small, medium, and large.
Based on the category, the market has been segregated into generic drugs, innovator drugs, biologic drugs, biosimilars, medical devices (therapeutic and diagnostic), and others.
On the basis of the indication, the market has been categorized into oncology, neurology, cardiology, immunology, and others.
Based on the stage, the market has been divided into preclinical, clinical, and post market authorization (PMA).
On the basis of the end user, the market has been segregated into medical device, pharmaceutical, and biotechnology companies.
Region-wise, the market has been classified into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.
The competitive landscape of the market has also been analyzed, with some of the key players being Charles River Laboratories International Inc., Covance Inc (Laboratory Corporation of America Holdings), Freyr, ICON Plc, Medpace Holdings Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, Promedica International- A California Corporation and Wuxi AppTec Co. Ltd.

Report Scope:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Segment Coverage	Services, Company Size, Category, Indication, Stage, End User, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Charles River Laboratories International Inc., Covance Inc (Laboratory Corporation of America Holdings), Freyr, ICON Plc, Medpace Holdings Inc., Parexel International Corporation, Pharmaceutical Product Development LLC, Promedica International- A California Corporation and Wuxi AppTec Co. Ltd.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Regulatory Affairs Outsourcing Market to Reach US$ 11.7 Billion by 2028, Propelled by the Exponential Growth in the Biotechnological and Pharmaceutical Industries

Purchase options Year End sale

Single User License ~~$2499~~ $2249
Five User License ~~$3499~~ $2974
Corporate License ~~$4499~~ $3599

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.